메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Cranial Technologies Debuts NMPA-Cleared Infant Head Reshaping Treatment in China at CIIE

SHANGHAI, Nov. 7, 2025 -- Cranial Technologies, a leading US medical device company specializing in the treatment of infant head shape conditions, officially introduced its flagship DOC Band® treatment in the Chinese market at the China International Import Expo (CIIE), taking place from November 5 to 10, 2025, in Shanghai. Cranial Technologies has treated over 400,000 infants across the United States and Europe. Its participation in CIIE marks a major milestone in the company's global expansion and its first entry into the Chinese market. "We are truly honored to parti
- 김갑성 기자
- 2025-11-07 15:58
Harbour BioMed and Evinova China Announce Strategic AI Collaboration to Accelerate AI-Enabled Drug Development

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 7, 2025 -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Evinova, a global health-tech company accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, announced a strategic collaboration in artificial intelligence (AI). Under the terms of the collaboration, Harbour BioMed and Ev
- 김갑성 기자
- 2025-11-07 14:00
Fosun International Honored with Gold Award and Best Sustainability Team at The Asset Corporate Sustainability Leadership Awards 2025

HONG KONG, Nov. 7, 2025 -- On the evening of 6 November 2025, The Asset, a renowned Asian financial magazine, hosted "The Asset Corporate Sustainability Leadership Awards 2025" ceremony in Singapore. Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) was awarded "The Asset Corporate Sustainability Leadership Awards 2025 – Gold Award" and the "Best Sustainability Team". Coinciding with The Asset's 25th anniversary, the highly regarded "The Asset ESG Corporate Awards" was renamed "
- 김갑성 기자
- 2025-11-07 09:00
Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence

The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 7, 2025 -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and therapeutics, today announced that Volpara Health Technologies will now operate under the Lunit brand, introducing a unified global identity that merges their complementary strengths in breast health and AI innovation. This milestone builds on Lunit's 2024 acquisition of Volpara, an important step tha
- 김갑성 기자
- 2025-11-07 08:14
ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut

SUZHOU, China, Nov. 7, 2025 -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced that the Company will present one of its autoimmune and inflammation pipeline assets, CS2015 (OX40L/TSLP bispecific antibody), in the format of an ePoster plus an on-site oral presentation at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI). ACAAI is one of the most influe
- 김갑성 기자
- 2025-11-07 08:10
Australian Sleep Tech Company Launches a Smart Ring to Transform Sleep & Health - retimer Ring

ADELAIDE, Australia, Nov. 7, 2025 -- Re-Time Pty Ltd (RTPL) today announced the launch of the retimer Ring, the first smart ring solution developed by an Australian company to help people improve sleep and overall wellbeing. Building on a legacy of more than 25 years of research at Flinders University, the company widens its offering in the sleep wearable space with the retimer Ring. RTPL first gained global recognition in 2015 with its blue-green light therapy glasses, which continue to help thousands of people around the world with circadian sleep problems - delayed sleep, j
- 김갑성 기자
- 2025-11-07 07:00
Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally

SYDNEY, Nov. 7, 2025 -- Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close of its A$25 million Series B financing round. The round was led by Aviron Investment Management with continued participation from Oncology Ventures. This funding highlights the strong clinical adoption of Lumonus AI, with leading health systems across the United States, Australia, and Europe who are already integrating the platform into routine clinical care. To date, the Lumonus AI platform has supported clinicians in consulting and prescribing over
- 김갑성 기자
- 2025-11-07 06:00
Jungbunzlauer closes acquisition of Illinois facility to launch U.S. manufacturing operations

– Strategic investment enhances service to North American customers and supports rising market demand for high-quality ingredients – BASEL, Switzerland, Nov. 6, 2025 -- Jungbunzlauer, a global leader in high-quality ingredients from natural sources, today announced the successful closing of its acquisition of the production site in Thomson, Illinois from International Flavors & Fragrances, Inc. (IFF). This milestone marks Jungbunzlauer's first U.S. manufacturing facility, enhancing its ability to serve North American customers with greater proximity and responsivene
- 황정호 기자
- 2025-11-06 22:00
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

BELLEVUE, Wash., Nov. 6, 2025 -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced the key findings from a company-sponsored pilot study conducted by Woori IO, an OSR Company, in collaboration with Korea University Guro Hospital. The study, which took place from May 9 to September 12, 2023, evaluated the performance of the Glucheck blood glucose measurement system and validated its accuracy, stability, and usability across a representative participant group. Although the Clinical Study Report (CSR) for this exploratory trial was completed in 2023, Woori IO, then a
- 김갑성 기자
- 2025-11-06 21:30
KGC Launches Premium Ingredient Brand "G1899," for the Global B2B Health Ingredient Market

KGC, a Global Health Leader, Expands into the B2B Ingredient Sector with Its Standardized Premium Brand "G1899" Showcases "G1899" at the World's Largest Ingredient Exhibition, SSG 2025, Highlighting the Excellence of Red Ginseng Demonstrates KGC's Quality Management Systems and Advanced R&D Capabilities for Sourcing High-Purity Natural Ingredients Plans to Standardize Red Ginseng and Other Natural Ingredients to Bring JungKwanJang's Science-backed benefits to Global Partners SEOUL, South Korea, Nov. 6, 2025 -- Global health and wellness compa
- 김갑성 기자
- 2025-11-06 21:00

이전

51 52 53 54 55 56 57 58 59 60

많이 본 기사

최근기사

2026-01-01_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 01일 22시 40분